Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0–HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants

Journal of Clinical Virology - Tập 71 - Trang 76-81 - 2015
Thomas Mourez1,2,3, Constance Delaugerre4,5, Muriel Vray6, Véronique Lemée3, François Simon4,5, Jean-Christophe Plantier1,2,3
1Normandie Université, France
2Université de Rouen, Institut de Recherche et d'Innovation Biomédicale (IRIB), Equipe d'Accueil 2656, F-76183 Rouen, France
3CHU de Rouen, Laboratoire de Virologie Associé au Centre National de Référence du VIH, F-76031 Rouen, France
4Université Denis Diderot Paris 7, F-75010 Paris, France
5AP-HP, hôpital Saint-Louis, Laboratoire de Virologie, F-75010 Paris, France
6Institut Pasteur, Unité d'Epidémiologie des Maladies Emergentes, F-75014 Paris, France

Tài liệu tham khảo

Hemelaar, 2011, Global trends in molecular epidemiology of HIV-1 during 2000–2007, AIDS, 25, 679, 10.1097/QAD.0b013e328342ff93 Gueudin, 2007, Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes, J. Acquir. Immune Defic. Syndr., 44, 500, 10.1097/QAI.0b013e31803260df Wirden, 2009, Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes, J. Clin. Microbiol., 47, 1543, 10.1128/JCM.02134-08 Damond, 2007, Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1. 5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays, J. Clin. Microbiol., 45, 3436, 10.1128/JCM.00973-07 Bourlet, 2011, HIV-1 load comparison using four commercial real-time assays, J. Clin. Microbiol., 49, 292, 10.1128/JCM.01688-10 Delaugerre, 2009, Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient, J. Clin. Microbiol., 47, 3763, 10.1128/JCM.00206-09 Mourez, 2013, Non-M variants of human immunodeficiency virus type 1, Clin. Microbiol. Rev., 26, 448, 10.1128/CMR.00012-13 Plantier, 2003, Plasma RNA quantification and HIV-divergent strains, J. Acquir. Immune Defic. Syndr., 33, 1, 10.1097/00126334-200305010-00001 Sire, 2011, Comparative RNA Quantification of HIV-1 Group M and Non-M With the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2. 0 and Abbott real-time HIV-1 PCR Assays, J. Acquir. Immune Defic. Syndr., 56, 239, 10.1097/QAI.0b013e3182099891 Gomes, 2013, Comparison of the NucliSENS EasyQ HIV -1 v2. 0 with Abbott m2000rt RealTime HIV -1 assay for plasma RNA quantitation in different HIV -1 subtypes, J. Virol. Methods, 10.1016/j.jviromet.2013.05.001 Muenchhoff, 2014, Evaluation of the NucliSens EasyQ v2. 0 assay in comparison with the Roche Amplicor v1. 5 and the Roche CAP/CTM HIV-1 Test v2. 0 in quantification of C-clade HIV-1 in plasma, PLoS One, 9, e103983, 10.1371/journal.pone.0103983 Xu, 2012, Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China, J. Clin. Virol., 53, 33, 10.1016/j.jcv.2011.10.001 Simon, 1996, HIV type 1 diversity in northern Paris, France, AIDS Res. Hum. Retroviruses, 12, 1427, 10.1089/aid.1996.12.1427 Simon, 2001, Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses, AIDS Res. Hum. Retroviruses, 17, 937, 10.1089/088922201750290050 Delaugerre, 2012, Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients, PLoS One, 7, e36673, 10.1371/journal.pone.0036673 Damond, 2010, Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification, J. Clin. Microbiol., 48, 1413, 10.1128/JCM.01409-09 Scott, 2009, J. Clin. Microbiol., 47, 2209, 10.1128/JCM.01761-08 Swanson, 2005, Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1. 5, VERSANT HIV-1 RNA 3. 0, and NucliSens HIV-1 QT, J. Clin. Microbiol., 43, 3860, 10.1128/JCM.43.8.3860-3868.2005 Delaugerre, 2011, HIV-1 group N: travelling beyond Cameroon, Lancet, 378, 1894, 10.1016/S0140-6736(11)61457-8 Tang, 2007, A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples, J. Virol. Methods, 146, 236, 10.1016/j.jviromet.2007.07.003 Gueudin, 2012, A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection, J. Clin. Microbiol., 50, 831, 10.1128/JCM.05669-11 Yeni, 2010